Skip to content

Ticker

ARCH:TSXV ACHFF:OTC
Arch Biopartners
Arch Biopartners
  • About usOur story, our approach
  • Our ScienceKey platform & published data
    • Key Platform
      • LSALT Peptide – Treatment for Inflammation
    • Journal Publications
      • Recent Publications
      • Treatments for Inflammation
      • AB569
      • Brain Tumor Stem Cell Targeting
      • Borg Peptide Solid Surface Interface
  • Investor HubFundamentals, reports & filings
    • Fundamentals
      • Press Releases
      • Stock Performance
      • Investor Information
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Financial Statements
      • Proxies and Management Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Our TeamScience leaders & management team
    • Science Teams
      • LSALT Peptide Scientists
      • Treatments for Inflammation Scientists
      • AB569 Science Lead
      • BORG Peptide Solid Surface Interface Scientists
    • Management & Directors
      • Executive Team
      • Board of Directors and Advisors
  • Contact Us
Arch Biopartners
  • About usOur story, our approach
  • Our ScienceKey platform & published data
    • Key Platform
      • LSALT Peptide – Treatment for Inflammation
    • Journal Publications
      • Recent Publications
      • Treatments for Inflammation
      • AB569
      • Brain Tumor Stem Cell Targeting
      • Borg Peptide Solid Surface Interface
  • Investor HubFundamentals, reports & filings
    • Fundamentals
      • Press Releases
      • Stock Performance
      • Investor Information
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Financial Statements
      • Proxies and Management Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Our TeamScience leaders & management team
    • Science Teams
      • LSALT Peptide Scientists
      • Treatments for Inflammation Scientists
      • AB569 Science Lead
      • BORG Peptide Solid Surface Interface Scientists
    • Management & Directors
      • Executive Team
      • Board of Directors and Advisors
  • Contact Us

Media

  Home

Metablok – Webinar August 2020

Videos & Media
Contact Arch Biopartners
Stay connected!

Contact Arch Biopartners

Stay connected to receive investor news and email alerts!

Quick Links

Home About Us Our Science Our Team Investor Hub Contact Us
Legal
Terms of Use Privacy Policy Cookie Policy Legal Notices

Connect

+1 647 428 7031

Mailing Address

27 St. Clair Ave E.
P.O. Box 305
Toronto, Ontario
Canada M4T 2M5

© 2023 Arch Biopartners

  • About usOur story, our approach
  • Our ScienceKey platform & published data
    • Key Platform
      • LSALT Peptide – Treatment for Inflammation
    • Journal Publications
      • Recent Publications
      • Treatments for Inflammation
      • AB569
      • Brain Tumor Stem Cell Targeting
      • Borg Peptide Solid Surface Interface
  • Investor HubFundamentals, reports & filings
    • Fundamentals
      • Press Releases
      • Stock Performance
      • Investor Information
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Financial Statements
      • Proxies and Management Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Our TeamScience leaders & management team
    • Science Teams
      • LSALT Peptide Scientists
      • Treatments for Inflammation Scientists
      • AB569 Science Lead
      • BORG Peptide Solid Surface Interface Scientists
    • Management & Directors
      • Executive Team
      • Board of Directors and Advisors
  • Contact Us